2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors

1992 ◽  
Vol 35 (13) ◽  
pp. 2363-2368 ◽  
Author(s):  
Gloria Cristalli ◽  
Alessandra Eleuteri ◽  
Sauro Vittori ◽  
Rosaria Volpini ◽  
Martin J. Lohse ◽  
...  
2003 ◽  
Vol 68 (11) ◽  
pp. 2201-2218 ◽  
Author(s):  
Michal Česnek ◽  
Antonín Holý ◽  
Milena Masojídková

A series of the new 2-alkynyl derivatives of the acyclic nucleoside 9-(2,3-dihydroxypropyl)- adenine and their 6-guanidinopurine analogues were prepared by the Sonogashira coupling. The effect of the prepared compounds on A1 and A2A receptors was examined.


Author(s):  
Claudia Martini ◽  
Gino Giannaccini ◽  
Antonio Lucacchini ◽  
Laura Bazzichi ◽  
Annalia Soletti ◽  
...  

1990 ◽  
Vol 22 ◽  
pp. 431
Author(s):  
A.M. Rosati ◽  
C. Florio ◽  
U. Traversa ◽  
R. Vertua

2014 ◽  
Vol 11 (1) ◽  
pp. 96-101 ◽  
Author(s):  
B Suvarna

Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer. DOI: http://dx.doi.org/10.3126/kumj.v11i1.11054 Kathmandu University Medical Journal Vol.11(1) 2013: 96-101


2013 ◽  
Vol 85 (9) ◽  
pp. 1317-1329 ◽  
Author(s):  
Benjamin F. Seibt ◽  
Anke C. Schiedel ◽  
Dominik Thimm ◽  
Sonja Hinz ◽  
Farag F. Sherbiny ◽  
...  

1985 ◽  
Vol 63 (1) ◽  
pp. 58-61 ◽  
Author(s):  
H. P. Baer ◽  
M. Morr

Several amino- and ammonio-substituted derivatives of adenosine were tested as effectors of adenosine receptors in different smooth muscle preparations and mouse neuroblastoma adenylate cyclase. The compounds did not affect adenosine receptors in smooth muscles. N6-[3-(trimethylammonio)propyl]adenosine was a weak stimulator of adenylate cyclase, and 3′-amino-3′-deoxyadenosine and 3′-rnonomethylamino-3′-deoxyadenosine antagonized the stimulation of adenylate cyclase by 2-chloroadenosine.


1987 ◽  
Vol 30 (1) ◽  
pp. 211-214 ◽  
Author(s):  
Kenneth A. Jacobson ◽  
Dieter Ukena ◽  
William Padgett ◽  
John W. Daly ◽  
Kenneth L. Kirk

1992 ◽  
Vol 12 (2) ◽  
pp. 149-169 ◽  
Author(s):  
Xiao-Duo Ji ◽  
Gary L. Stiles ◽  
Philip J.M. van Galen ◽  
Kenneth A. Jacobson

Sign in / Sign up

Export Citation Format

Share Document